Faculty of Biological Sciences

Research Bulletin

New centre to revolutionise medical technology

27th February 2013

The University of Leeds is leading a £5.7 million, government-backed initiative to transform the way replacement joints and other medical implants are made.

The Centre for Innovative Manufacturing in Medical Devices will bring together academics and industrialists in a bid to maintain the UK's leading role in the medical technologies industry and improve the quality of lives of patients.

It is one of four new centres for innovative manufacturing announced by Minister for Universities and Science David Willetts that will share a pot of £21 million grant funding from the Engineering and Physical Sciences Research Council (EPSRC) when they open later this year.

Professor John Fisher, Deputy Vice-Chancellor of the University of Leeds and Professor of Mechanical Engineering, will lead the new centre. He said: "The medical technology market is estimated to be worth £200 billion worldwide and demand for medical devices is growing fast, driven by ageing populations that expect longer and fuller lives.

"We want to develop new ways of designing and manufacturing devices that meet the needs of particular patients and bring the manufacturing of devices much closer to them," he added. "Instead of doctors ordering, unpacking and fitting implants, we want devices to be personalised to meet individuals' needs and be made in or near the clinical setting."

The centre will bring together leading companies and five UK centres of excellence in medical technology and manufacturing at Leeds, Newcastle University, the University of Nottingham, the University of Sheffield and the University of Bradford.

The Faculty of Biological Sciences has researchers, such as Professor Eileen Ingham, which are key to this new Centre in the Institute of Medical and Biological Engineering (iMBE), one of the UK's leading bioengineering research institutions. It has pioneered work on longer-lasting joint replacements, revolutionary spinal interventions and biological scaffolds for tissue repair that grow with the body.

The initial focus of the new centre's work will be on medical devices for musculoskeletal and cardiovascular disease, where the cost of failure is high and the need for devices that keep working for a patient's whole life is clear.

The centre will also develop a network of over 300 industrial partners, academics and clinicians focused on medical device innovation and manufacturing. The network will lead the development of new international standards to overcome barriers to adoption in global markets and support the adoption of new technology in the NHS by working with the new Academic Health Science Networks.

The £21 million for the four new centres for innovative manufacturing was part of a £45 million package of investments in manufacturing research announced by Dr Willetts ahead of the BIS Manufacturing Summit.

"The UK has a proud history of manufacturing but to build on this success industry needs access to the very latest science and technology," Dr Willetts said. "This £45 million package of investment will see our world-class research base investigating innovative new manufacturing equipment and techniques. This will support our industrial strategy in a range of important sectors, driving growth and keeping the UK ahead in the global race."

EPSRC's Chief Executive, Professor David Delpy said: "EPSRC Centres of Innovative Manufacturing are building on previous investments we have made in the research base and combining academic innovation with industry knowledge. These new centres are in areas that are strategically important to the UK and the work there will push research boundaries and drive growth."


Recent Grants

Mike McPherson (and colleagues in the School of Chemistry), EPSRC (Jul 2014), £819,880

Sheena Radford, Univesity of Michigan (Jul 2014), £138,452

Chris West, Leverhulme Trust (Jun 2014), £181,241

Jon Lippiat, Darren Tomlinson, BBSRC (May 2014), £125,174

David Brockwell, Sheena Radford, Medimmune Ltd (Apr 2014), £337,661

Peter Stockley, Wellcome Trust (Apr 2014), £251,019

Mike McPherson, Wellcome Trust (Apr 2014), £146,596

Andrew Macdonald, Kidney Research Fund UK (Apr 2014), £127,237

Mike McPherson (and colleagues in School of Design), Technology Strategy Board (Apr 2014), £114,350

Paul Millner, Peter Stockley, Darren Tomlinson, YCR (Apr 2014), £95,874

Carrie Ferguson, Karen Birch, Shaunna Burke, Heart Research UK (Apr 2014), £60,140

Dave Westhead, MRC (Apr 2014), £18,304

Brendan Davies, BBSRC (Mar 2014), £451,829

Jim Deuchars, MRC (Mar 2014), £300,000

Adam Kupinski, Children with Cancer (Mar 2014), £50,000

Alison Baker, Steve Baldwin, BBSRC (Feb 2014), £403,439

Sarah Zylinski, BBSRC (Feb 2014), £355,869

Dave Lewis, Nigel Hooper, Tony Turner, Hugh Pearson, James Duce, Alzheimer's Society (Feb 2014), £29,871

Ronaldo Ichyama, Samit Chakrabarty, International Spinal Research Trust (Jan 2014), £304,600

Brendan Davies, BBSRC/Bayer Crop Science SA-NV (Jan 2014), £470,053

Adrian Goldman, Steve Baldwin, Stephen Muench, Thomas Edwards, Arwen Pearson , BBSRC (Jan 2014), £467,103

Stefan Kepinski, BBSRC (Jan 2014), £359,269

Elwyn Isaac, EU (Jan 2014), £179,445

Dave Westhead, Leukaemia & Lymphoma Research (Jan 2014), £105,937

John Barr, Thomas Edwards, MRC (Dec 2013), £469,505

Alex O'Neill, MRC (Dec 2013), £349,017

Darren Tomlinson, Yorkshire Cancer Research (Nov 2013), £142,334

Nikita Gamper, MRC (Nov 2013), £336,563

Keith Hamer, Alison Dunn, NERC (Nov 2013), £47,233

Alan Berry, Wellcome Trust (Oct 2013), £749,365

Urwin, Howard Atkinson, BBSRC (Oct 2013), £360,508

Eileen Ingham, Stacey-Paul Wilshaw, NHS R&D (Oct 2013), £356,623

Sheena Radford, BBSRC (Oct 2013), £329,906

Nigel Hooper, Alzheimer's Research (Oct 2013), £327,075

Eileen Ingham, EPSRC (Oct 2013), £276,751

David Beech, BHF (Oct 2013), £109,974

Mark Harris, Medical Research Foundation (Oct 2013), £34,455

James Dachtler, Royal Society (Oct 2013), £15,000

Ade Whitehouse, Teresa Rosenbaum Golden Charitable Trust (Oct 2013), £10,000

Jurgen Denecke, BBSRC (Sep 2013), £382,093

Andy Cuming, EU (Sep 2013), £257,714

Paul Knox, BBSRC (Sep 2013), £411,948

Vas Ponnambalam, Leverhulme Trust (Sep 2013), £245,031

Peter Meyer, EU (Sep 2013), £242,166

Dave Rowlands, Nic Stonehouse, EU (Sep 2013), £202,556

Derek Steele, BHF (Sep 2013), £103,629

Joan Boyes, NC3Rs (Sep 2013), £90,000

Peter Stockley, Royal Society (Sep 2013), £11,400

Darren Tomlinson, Leverhulme Trust (Sep 2013), £5,645

Nic Stonehouse, Dave Rowlands, BBSRC (Aug 2013), £574,906

Eileen Ingham, Wellcome Trust (Aug 2013), £191,470

Adrian Goldman, Royal Society (Aug 2013), £75,000

Mike McPherson, Wellcome Trust (Aug 2013), £40,000

Recent News

Researchers find clue to stopping Alzheimer's-like diseases

2nd July 2014

Tiny differences in mice that make them peculiarly resistant to a family of conditions that includes Alzheimer's, Parkinson's and Creutzfeldt-Jakob Disease may provide clues for treatments in humans. more

Celebrating the work of a neglected scientific pioneer

18th June 2014

A University of Leeds academic has shed important new light on the fascinating story of a pioneer whose contribution to one of science's biggest discoveries has long been overlooked. more

Big data to help blood cancer patients

22nd May 2014

A pioneering database at the University of Leeds will help match patients with certain types of blood cancers to the best treatments. more

Leeds professor elected to Royal Society

1st May 2014

Sheena Radford, Professor of Structural Molecular Biology at the University of Leeds, has been made a fellow of the Royal Society. more

Health experts investigate new fitness regimes

1st May 2014

Researchers looking at ways to improve government physical activity guidelines and tackle Britain's fitness crisis are calling for volunteers to take part in a new study. more

Impact Stories

Professor Eileen Ingham has led research over many years to develop improved approaches to aid healing and repair of soft tissues.
more

Professor Miller has demonstrated a weanling pig feed formulation which avoids the use of antibiotics.
more

Evocutis offers a highly specialised portfolio of assays, models and clinical protocols focused entirely on skin science.
more

Research by Dr Simon Goodman shows how large the effect of human activity has been on the Caspian Seal.
more

All impact stories